Literature DB >> 34272315

Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?

Jakoba J Eertink1, Elisabeth A G Pfaehler2, Sanne E Wiegers1, Tim van, Pieternella J Lugtenburg3, Otto S Hoekstra4, Josée M Zijlstra1, Henrica C W de Vet5, Ronald Boellaard6.   

Abstract

Radiomics features may predict outcome in diffuse large B-cell lymphoma (DLBCL). Currently, multiple segmentation methods are used to calculate metabolic tumor volume (MTV). We assessed the influence of segmentation method on the discriminative power of radiomics features in DLBCL at the patient level and for the largest lesion.
Methods: Fifty baseline 18F-FDG PET/CT scans of DLBCL patients with progression or relapse within 2 years after diagnosis were matched on uptake time and reconstruction method with 50 baseline PET/CT scans of DLBCL patients without progression. Scans were analyzed using 6 semiautomatic segmentation methods (SUV threshold of 4.0 [SUV4.0], SUV threshold of 2.5, 41% of SUVmax, 50% of SUVpeak, a majority vote segmenting voxels detected by ≥2 methods, and a majority vote segmenting voxels detected by ≥3 methods). On the basis of these segmentations, 490 radiomics features were extracted at the patient level, and 486 features were extracted for the largest lesion. To quantify the agreement between features extracted from different segmentation methods, the intraclass correlation (ICC) agreement was calculated for each method compared with SUV4.0. The feature space was reduced by deleting features that had high Pearson correlations (≥0.7) with the previously established predictors MTV or SUVpeak Model performance was assessed using stratified repeated cross validation with 5 folds and 2,000 repeats, yielding the mean receiver-operating-characteristics curve integral for all segmentation methods using logistic regression with backward feature selection.
Results: The percentage of features yielding an ICC of at least 0.75, compared with the SUV4.0 segmentation, was lowest for 50% of SUVpeak both at the patient level and for the largest lesion, with 77.3% and 66.7% of the features yielding an ICC of at least 0.75, respectively. Features did not correlate strongly with MTV, with at least 435 features at the patient level and 409 features for the largest lesion for all segmentation methods having a correlation coefficient of less than 0.7. Features correlated strongly with SUVpeak (at least 190 at patient level and 134 for the largest lesion were uncorrelated to SUVpeak, respectively). Receiver-operating-characteristics curve integrals ranged between 0.69 ± 0.11 and 0.84 ± 0.09 at the patient level and between 0.69 ± 0.11 and 0.73 ± 0.10 at the lesion level.
Conclusion: Even though there are differences in the actual radiomics feature values derived and selected features among segmentation methods, there is no substantial difference in the discriminative power of radiomics features among segmentation methods.
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  18F-FDG PET/CT; diffuse large B-cell lymphoma; radiomics; segmentation methods

Mesh:

Substances:

Year:  2021        PMID: 34272315      PMCID: PMC8978204          DOI: 10.2967/jnumed.121.262117

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  32 in total

1.  Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.

Authors:  Michael Crump; Sattva S Neelapu; Umar Farooq; Eric Van Den Neste; John Kuruvilla; Jason Westin; Brian K Link; Annette Hay; James R Cerhan; Liting Zhu; Sami Boussetta; Lei Feng; Matthew J Maurer; Lynn Navale; Jeff Wiezorek; William Y Go; Christian Gisselbrecht
Journal:  Blood       Date:  2017-08-03       Impact factor: 22.113

2.  Approximate Statistical Tests for Comparing Supervised Classification Learning Algorithms.

Authors: 
Journal:  Neural Comput       Date:  1998-09-15       Impact factor: 2.026

3.  18F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome.

Authors:  Anne-Ségolène Cottereau; Christophe Nioche; Anne-Sophie Dirand; Jérôme Clerc; Franck Morschhauser; Olivier Casasnovas; Michel Meignan; Irène Buvat
Journal:  J Nucl Med       Date:  2019-06-14       Impact factor: 10.057

4.  Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium.

Authors:  Sally F Barrington; Ben G J C Zwezerijnen; Henrica C W de Vet; Martijn W Heymans; N George Mikhaeel; Coreline N Burggraaff; Jakoba J Eertink; Lucy C Pike; Otto S Hoekstra; Josée M Zijlstra; Ronald Boellaard
Journal:  J Nucl Med       Date:  2020-07-17       Impact factor: 10.057

5.  Robustness of intratumour ¹⁸F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma.

Authors:  Mathieu Hatt; Florent Tixier; Catherine Cheze Le Rest; Olivier Pradier; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-16       Impact factor: 9.236

6.  Pretreatment 18F-FDG PET/CT Radiomics Predict Local Recurrence in Patients Treated with Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: A Multicentric Study.

Authors:  Gurvan Dissaux; Dimitris Visvikis; Ronrick Da-Ano; Olivier Pradier; Enrique Chajon; Isabelle Barillot; Loig Duvergé; Ingrid Masson; Ronan Abgral; Maria-Joao Santiago Ribeiro; Anne Devillers; Amandine Pallardy; Vincent Fleury; Marc-André Mahé; Renaud De Crevoisier; Mathieu Hatt; Ulrike Schick
Journal:  J Nucl Med       Date:  2019-11-15       Impact factor: 10.057

7.  18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.

Authors:  Mathieu Hatt; Mohamed Majdoub; Martin Vallières; Florent Tixier; Catherine Cheze Le Rest; David Groheux; Elif Hindié; Antoine Martineau; Olivier Pradier; Roland Hustinx; Remy Perdrisot; Remy Guillevin; Issam El Naqa; Dimitris Visvikis
Journal:  J Nucl Med       Date:  2014-12-11       Impact factor: 10.057

8.  Tumor texture analysis in 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis.

Authors:  Fanny Orlhac; Michaël Soussan; Jacques-Antoine Maisonobe; Camilo A Garcia; Bruno Vanderlinden; Irène Buvat
Journal:  J Nucl Med       Date:  2014-02-18       Impact factor: 10.057

9.  The effect of small tumor volumes on studies of intratumoral heterogeneity of tracer uptake.

Authors:  Frank J Brooks; Perry W Grigsby
Journal:  J Nucl Med       Date:  2013-11-21       Impact factor: 10.057

10.  The effects of segmentation algorithms on the measurement of 18F-FDG PET texture parameters in non-small cell lung cancer.

Authors:  Usman Bashir; Gurdip Azad; Muhammad Musib Siddique; Saana Dhillon; Nikheel Patel; Paul Bassett; David Landau; Vicky Goh; Gary Cook
Journal:  EJNMMI Res       Date:  2017-07-26       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.